Impact of human leukocyte antigen-B*51-restricted cytotoxic T-lymphocyte pressure on mutation patterns of nonnucleoside reverse transcriptase inhibitor resistance.
Page:
F15-F22
Weighing the gold in the gold standard: challenges in HIV prevention research.
Page:
621-635
Mechanism of protection of live attenuated simian immunodeficiency virus: coevolution of viral and immune responses.
Page:
637-648
Platelet function and HIV: a case-control study.
Page:
649-657
N348I in reverse transcriptase provides a genetic pathway for HIV-1 to select thymidine analogue mutations and mutations antagonistic to thymidine analogue mutations.
Page:
659-667
High prevalence of bevirimat resistance mutations in protease inhibitor-resistant HIV isolates.
Page:
669-673
Prevention of tuberculosis in Bacille Calmette-Guerin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine.
Page:
675-685
Total body and spinal bone mineral density across Tanner stage in perinatally HIV-infected and uninfected children and youth in PACTG 1045.
Page:
687-696
Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV.
Page:
697-706
Abacavir and tenofovir disoproxil fumarate co-administration results in a nonadditive antiviral effect in HIV-1-infected patients.
Page:
707-716
HIV genital shedding and safety of Carraguard use by HIV-infected women: a crossover trial in Thailand.
Page:
717-722
Late diagnosis in the HAART era: proposed common definitions and associations with mortality.
Page:
723-727
Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings.
Page:
729-735
Male circumcision and risk of male-to-female HIV-1 transmission: a multinational prospective study in African HIV-1-serodiscordant couples.
Page:
737-744
Survival of HIV-infected patients with compensated liver cirrhosis.
Page:
745-753